Charles Schwab’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.6M Buy
458,942
+6,331
+1% +$934K 0.01% 1099
2026
Q1
$65M Buy
452,611
+30,267
+7% +$4.98M 0.01% 981
2025
Q4
$73.6M Buy
422,344
+4,801
+1% +$881K 0.01% 895
2025
Q3
$85.7M Sell
417,543
-172,196
-29% -$33.8M 0.01% 804
2025
Q2
$106M Sell
589,739
-9,028
-2% -$1.52M 0.02% 657
2025
Q1
$96.7M Sell
598,767
-4,189
-0.7% -$719K 0.02% 669
2024
Q4
$105M Buy
602,956
+1,931
+0.3% +$340K 0.02% 638
2024
Q3
$95M Buy
601,025
+149,114
+33% +$22.3M 0.02% 685
2024
Q2
$60.9M Buy
451,911
+7,541
+2% +$987K 0.01% 925
2024
Q1
$57M Buy
444,370
+14,218
+3% +$1.76M 0.01% 942
2023
Q4
$51.6M Buy
430,152
+14,985
+4% +$1.62M 0.01% 959
2023
Q3
$44.5M Buy
415,167
+38,587
+10% +$3.98M 0.01% 958
2023
Q2
$37M Sell
376,580
-104,654
-22% -$9.47M 0.01% 1081
2023
Q1
$42.1M Buy
481,234
+14,769
+3% +$1.39M 0.01% 957
2022
Q4
$40.7M Buy
466,465
+14,578
+3% +$1.31M 0.01% 951
2022
Q3
$34.1M Buy
451,887
+14,332
+3% +$1.16M 0.01% 1013
2022
Q2
$34.5M Sell
437,555
-1,920
-0.4% -$161K 0.01% 1005
2022
Q1
$38.6M Buy
439,475
+6,294
+1% +$648K 0.01% 1051
2021
Q4
$44.8M Buy
433,181
+7,955
+2% +$849K 0.01% 973
2021
Q3
$39.2M Buy
425,226
+5,266
+1% +$461K 0.01% 1042
2021
Q2
$34.3M Buy
419,960
+15,119
+4% +$1.09M 0.01% 1144
2021
Q1
$26.9M Buy
404,841
+12,867
+3% +$868K 0.01% 1279
2020
Q4
$26.4M Buy
391,974
+10,258
+3% +$665K 0.01% 1197
2020
Q3
$22.5M Buy
381,716
+5,744
+2% +$329K 0.01% 1124
2020
Q2
$20.9M Buy
375,972
+39,633
+12% +$2.31M 0.01% 1129
2020
Q1
$17.5M Buy
336,339
+24,534
+8% +$1.27M 0.01% 1099
2019
Q4
$15.2M Buy
311,805
+26,095
+9% +$1.23M 0.01% 1401
2019
Q3
$12.9M Buy
285,710
+58,319
+26% +$2.58M 0.01% 1436
2019
Q2
$10.1M Buy
227,391
+16,322
+8% +$763K 0.01% 1589
2019
Q1
$9.68M Buy
211,069
+21,182
+11% +$935K 0.01% 1617
2018
Q4
$6.99M Buy
189,887
+3,142
+2% +$128K 0.01% 1699
2018
Q3
$8.39M Buy
186,745
+17,304
+10% +$838K 0.01% 1750
2018
Q2
$8.68M Buy
169,441
+22,114
+15% +$1.06M 0.01% 1691
2018
Q1
$6.57M Buy
147,327
+16,181
+12% +$766K 0.01% 1790
2017
Q4
$5.96M Buy
131,146
+10,576
+9% +$453K ﹤0.01% 1829
2017
Q3
$4.72M Buy
120,570
+73,670
+157% +$2.69M ﹤0.01% 1900
2017
Q2
$1.64M Buy
46,900
+26,800
+133% +$910K ﹤0.01% 2290
2017
Q1
$693K Hold
20,100
﹤0.01% 2540
2016
Q4
$626K Hold
20,100
﹤0.01% 2580
2016
Q3
$504K Hold
20,100
﹤0.01% 2610
2016
Q2
$450K Hold
20,100
﹤0.01% 2624
2016
Q1
$501K Hold
20,100
﹤0.01% 2580
2015
Q4
$527K Buy
+20,100
New +$458K ﹤0.01% 2622

Other funds holding HLI

Charles Schwab's HLI Position: Q2 2026 in Review

Charles Schwab increased its Houlihan Lokey (HLI) stake by 1.4% in Q2 2026, buying an estimated $934K and bringing the position to 458,942 shares worth $61.6M. The position accounts for 0.01% of the portfolio, ranked #1099.

Charles Schwab first reported a position in HLI in Q4 2015 and has held it in 43 quarters since. The position peaked at $106M in Q2 2025. 515 funds tracked by Wall St. Rank hold HLI as of Q2 2026.

  • Charles Schwab held 458,942 shares of Houlihan Lokey worth $61.6M as of Q2 2026.
  • Charles Schwab bought 6,331 Houlihan Lokey shares in Q2 2026, an estimated $934K.
  • Houlihan Lokey made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1099 holding.
  • Charles Schwab first reported a position in Houlihan Lokey in Q4 2015 and has held it in 43 quarters since.
  • Charles Schwab's Houlihan Lokey position peaked at $106M in Q2 2025.
  • 515 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.